A committee of independent directors of Krebs Biochemicals and Industries has approved the open offer made by IPCA Laboratories to buy 26 per cent stake in the former at ₹54 a share. In February, IPCA Laboratories had made an open offer to buy 35.7 lakh shares of Krebs Biochemicals of which 23 lakh shares were to be bought on preferential basis. Shares of IPCA Laboratories slipped 2.3 per cent at ₹752.75 while those of Krebs Biochemicals closed at ₹123.30, down 0.9 per cent on the BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.